Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹69.50 Cr |
| Reserved for Market Maker | ₹3.92 Cr |
| Net Issue Size | ₹69.50 Cr |
| Fresh Issue | ₹65.58 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹137.00-145.00 per share |
| NSE Code | ANONDITA |
| Registrar | Maashitla Securities Pvt.Ltd. |
| Lead Managers | Narnolia Financial Services Ltd. |
| Allotment Status | |
| DRHP |
| RHP |
| Final Prospectus |
| Anchor List |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares · Multiples of 1,000 shares
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually.
The company has a manufacturing facility situated in Noida, Uttar Pradesh.
Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East.
The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives.
Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets.
The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives.
As on July 31, 2025, the Company had 280 employees.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | 6.00 |
| 2 | Funding the working capital requirements of the Company | 35.00 |
| 3 | Unidentified Acquisition and General Corporate Purposes | 20.16 |
| 4 | Issue Expenses | 8.34 |
| Total | 69.50 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 78.27 | 42.92 | 37.80 |
| Total Income | 77.13 | 46.56 | 36.14 |
| Profit After Tax | 16.42 | 3.84 | 0.35 |
| EBITDA | 25.65 | 9.09 | 3.58 |
| NET Worth | 37.87 | 10.59 | 8.69 |
| Reserves and Surplus | 24.58 | 10.39 | 6.55 |
| Total Borrowing | 27.39 | 24.01 | 22.66 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 41.71% |
| ROCE | 37.42% |
| Debt / Equity | 0.70% |
| RoNW | 41.71% |
| PAT Margin | 21.32% |
| EBITDA Margin | 33.32% |
| Price to Book Value | 15.07 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 12.35 | 9.08 |
| P/E (x) | 11.74 | 15.98 |
| Promoter Holding | 83.95% | 61.71% |
| Market Cap | ₹262.26 Cr. | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead manager(s) fees including underwriting commission. | 3.00 |
| 2 | Brokerage, selling commission and upload fees. | 0.09 |
| 3 | Registrars to the issue | 0.12 |
| 4 | Printing, advertising and marketing expenses | 0.11 |
| 5 | Regulators including stock exchanges | 0.06 |
| 6 | Legal Advisors | 0.10 |
| 7 | Others, if any (Advisors to the company, Peer Review Auditors, and other misc. expenses) | 4.85 |
Last Updated on 06-May-2026 11:35:03
